These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 21999752

  • 1. Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.
    Riccioni G, Cipollone F, Santovito D, Scotti L, D'Orazio N, Mezzetti A, Bucciarelli T.
    Expert Opin Pharmacother; 2011 Dec; 12(17):2599-604. PubMed ID: 21999752
    [Abstract] [Full Text] [Related]

  • 2. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L, Manfredi R, Colangeli V, Trapani FF, Salvadori C, Magistrelli E, Danese I, Verucchi G, Serra C, Viale P.
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
    [Abstract] [Full Text] [Related]

  • 3. One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.
    Riccioni G, Vitulano N, Mancini B, Zanasi A, D'Orazio N.
    Pharmacology; 2010 Mar; 85(2):63-7. PubMed ID: 20110750
    [Abstract] [Full Text] [Related]

  • 4. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
    Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML, METEOR Study Group.
    JAMA; 2007 Mar 28; 297(12):1344-53. PubMed ID: 17384434
    [Abstract] [Full Text] [Related]

  • 5. Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study.
    Riccioni G, Bazzano LA, Bucciarelli T, Mancini B, di Ilio E, D'Orazio N.
    Expert Opin Pharmacother; 2008 Oct 28; 9(14):2403-8. PubMed ID: 18778179
    [Abstract] [Full Text] [Related]

  • 6. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
    Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, O'Leary DH, Grobbee DE, Crouse JR, METEOR Study Group.
    J Intern Med; 2009 Jun 28; 265(6):698-707. PubMed ID: 19298496
    [Abstract] [Full Text] [Related]

  • 7. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
    Crouse JR, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS, METEOR Study Group.
    Eur J Cardiovasc Prev Rehabil; 2010 Apr 28; 17(2):223-9. PubMed ID: 20038840
    [Abstract] [Full Text] [Related]

  • 8. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.
    Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, Chu B, Takaya N, Liu F, Polissar NL, Neradilek B, Raichlen JS, Cain VA, Waterton JC, Hamar W, Hatsukami TS.
    Am Heart J; 2008 Mar 28; 155(3):584.e1-8. PubMed ID: 18294500
    [Abstract] [Full Text] [Related]

  • 9. Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study).
    Ikeda K, Takahashi T, Yamada H, Matsui K, Sawada T, Nakamura T, Matsubara H, (for the PEACE Investigators).
    Eur J Prev Cardiol; 2013 Dec 28; 20(6):1069-79. PubMed ID: 22689416
    [Abstract] [Full Text] [Related]

  • 10. Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia.
    Igase M, Kohara K, Tabara Y, Nagai T, Ochi N, Kido T, Ochi M, Miki T.
    Menopause; 2012 Dec 28; 19(12):1294-9. PubMed ID: 22850442
    [Abstract] [Full Text] [Related]

  • 11. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
    Lind L, Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML, METEOR Study Group.
    J Am Soc Echocardiogr; 2012 Oct 28; 25(10):1120-1127.e1. PubMed ID: 22884641
    [Abstract] [Full Text] [Related]

  • 12. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P.
    Clin Ther; 2006 Jun 28; 28(6):933-42. PubMed ID: 16860175
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study.
    Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M, Justification For Atherosclerosis Regression Treatment (JART) Investigators.
    Circ J; 2013 Jun 28; 77(6):1526-33. PubMed ID: 23486191
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Asztalos BF, Le Maulf F, Dallal GE, Stein E, Jones PH, Horvath KV, McTaggart F, Schaefer EJ.
    Am J Cardiol; 2007 Mar 01; 99(5):681-5. PubMed ID: 17317371
    [Abstract] [Full Text] [Related]

  • 15. Randomized dose-response study of rosuvastatin in Japanese patients with hypercholesterolemia.
    Saito Y, Goto Y, Dane A, Strutt K, Raza A.
    J Atheroscler Thromb; 2003 Mar 01; 10(6):329-36. PubMed ID: 15037821
    [Abstract] [Full Text] [Related]

  • 16. Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.
    Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML, METEOR Study Investigators.
    J Am Soc Echocardiogr; 2012 Jan 01; 25(1):91-100. PubMed ID: 21982737
    [Abstract] [Full Text] [Related]

  • 17. Prevention of atherosclerosis in patients living with HIV.
    De Lorenzo F, Boffito M, Collot-Teixeira S, Gazzard B, McGregor JL, Shotliff K, Xiao H.
    Vasc Health Risk Manag; 2009 Jan 01; 5(1):287-300. PubMed ID: 19436663
    [Abstract] [Full Text] [Related]

  • 18. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
    Deguchi I, Horiuchi Y, Hayashi T, Sehara Y, Kato Y, Ohe Y, Fukuoka T, Maruyama H, Sano H, Nagamine Y, Tanahashi N.
    J Stroke Cerebrovasc Dis; 2014 Sep 01; 23(8):2007-2011. PubMed ID: 25066602
    [Abstract] [Full Text] [Related]

  • 19. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct 01; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 20. Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study.
    Zheng H, Li H, Wang Y, Li Z, Hu B, Li X, Fu L, Hu H, Nie Z, Zhao B, Wei D, Karlson BW, Bots ML, Meng X, Chen Y, Wang Y, METEOR-China Investigators.
    Stroke; 2022 Oct 01; 53(10):3004-3013. PubMed ID: 36017704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.